Imugene Limited (IUGNF)
USD 0.03
(4.0%)
USD 0.03
(4.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -140.93 Million AUD | -174.75% |
| 2023 | -51.29 Million AUD | -36.21% |
| 2022 | -37.65 Million AUD | -105.28% |
| 2021 | -18.34 Million AUD | -74.66% |
| 2020 | -10.5 Million AUD | -35.19% |
| 2019 | -7.76 Million AUD | -34.4% |
| 2018 | -5.78 Million AUD | -56.8% |
| 2017 | -3.68 Million AUD | 13.64% |
| 2016 | -4.26 Million AUD | -63.53% |
| 2015 | -2.61 Million AUD | -834.42% |
| 2014 | 355.44 Thousand AUD | 120.43% |
| 2013 | -1.73 Million AUD | -288.71% |
| 2012 | 921.74 Thousand AUD | 171.95% |
| 2011 | 338.93 Thousand AUD | 115.96% |
| 2010 | -2.12 Million AUD | 23.01% |
| 2009 | -2.75 Million AUD | -7.7% |
| 2008 | -2.56 Million AUD | 4.02% |
| 2007 | -2.66 Million AUD | 15.38% |
| 2006 | -3.15 Million AUD | -25.44% |
| 2005 | -2.51 Million AUD | -27.84% |
| 2004 | -1.96 Million AUD | 19.05% |
| 2003 | -2.42 Million AUD | -121.18% |
| 2002 | -1.09 Million AUD | 71.56% |
| 2001 | -3.86 Million AUD | 12.28% |
| 2000 | -4.4 Million AUD | 10.24% |
| 1999 | -4.9 Million AUD | -8.52% |
| 1998 | -4.51 Million AUD | -68.21% |
| 1997 | -2.68 Million AUD | 43.19% |
| 1996 | -4.72 Million AUD | -135.93% |
| 1995 | -2 Million AUD | -67.14% |
| 1994 | -1.19 Million AUD | -156.2% |
| 1993 | -468 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -67.55 Million AUD | 0.0% |
| 2024 Q1 | -35.5 Million AUD | -20.82% |
| 2024 Q2 | -79.23 Million AUD | -123.16% |
| 2024 FY | -140.93 Million AUD | -174.75% |
| 2023 Q2 | -21.9 Million AUD | -145.14% |
| 2023 Q3 | -10.82 Million AUD | 50.6% |
| 2023 FY | -51.29 Million AUD | -36.21% |
| 2023 Q4 | -29.38 Million AUD | -171.56% |
| 2023 Q1 | -8.93 Million AUD | 70.36% |
| 2022 Q1 | -7.6 Million AUD | 51.02% |
| 2022 FY | -37.65 Million AUD | -105.28% |
| 2022 Q4 | -30.15 Million AUD | -168.07% |
| 2022 Q3 | -11.24 Million AUD | 45.19% |
| 2022 Q2 | -20.52 Million AUD | -169.88% |
| 2021 Q2 | -10.14 Million AUD | -234.93% |
| 2021 Q1 | -3.02 Million AUD | 60.29% |
| 2021 FY | -18.34 Million AUD | -74.66% |
| 2021 Q4 | -15.52 Million AUD | -150.83% |
| 2021 Q3 | -6.18 Million AUD | 38.96% |
| 2020 Q4 | -7.62 Million AUD | -159.99% |
| 2020 FY | -10.5 Million AUD | -35.19% |
| 2020 Q3 | -2.93 Million AUD | 59.58% |
| 2020 Q2 | -7.25 Million AUD | -197.31% |
| 2020 Q1 | -2.44 Million AUD | 65.31% |
| 2019 Q1 | -1.86 Million AUD | -62.82% |
| 2019 FY | -7.76 Million AUD | -34.4% |
| 2019 Q4 | -7.03 Million AUD | -210.42% |
| 2019 Q3 | -2.26 Million AUD | -21.48% |
| 2019 Q2 | -1.86 Million AUD | 0.0% |
| 2018 Q1 | -823.04 Thousand AUD | -58.72% |
| 2018 Q2 | -823.04 Thousand AUD | 0.0% |
| 2018 Q3 | -1.14 Million AUD | -39.18% |
| 2018 Q4 | -1.14 Million AUD | 0.0% |
| 2018 FY | -5.78 Million AUD | -56.8% |
| 2017 FY | -3.68 Million AUD | 13.64% |
| 2017 Q4 | -518.55 Thousand AUD | 0.0% |
| 2017 Q3 | -518.55 Thousand AUD | 30.1% |
| 2017 Q2 | -741.86 Thousand AUD | 0.0% |
| 2017 Q1 | -741.86 Thousand AUD | 8.97% |
| 2016 Q1 | -537.33 Thousand AUD | 13.17% |
| 2016 Q4 | -814.94 Thousand AUD | 0.0% |
| 2016 Q3 | -814.94 Thousand AUD | -51.66% |
| 2016 Q2 | -537.33 Thousand AUD | 0.0% |
| 2016 FY | -4.26 Million AUD | -63.53% |
| 2015 Q4 | -618.79 Thousand AUD | 0.0% |
| 2015 FY | -2.61 Million AUD | -834.42% |
| 2015 Q1 | -504.15 Thousand AUD | -283.96% |
| 2015 Q2 | -504.15 Thousand AUD | 0.0% |
| 2015 Q3 | -618.79 Thousand AUD | -22.74% |
| 2014 Q3 | -131.3 Thousand AUD | 50.9% |
| 2014 Q4 | -131.3 Thousand AUD | 0.0% |
| 2014 Q2 | -267.44 Thousand AUD | 0.0% |
| 2014 Q1 | -267.44 Thousand AUD | -65.66% |
| 2014 FY | 355.44 Thousand AUD | 120.43% |
| 2013 FY | -1.73 Million AUD | -288.71% |
| 2013 Q3 | -161.44 Thousand AUD | 0.0% |
| 2013 Q4 | -161.44 Thousand AUD | 0.0% |
| 2012 FY | 921.74 Thousand AUD | 171.95% |
| 2011 FY | 338.93 Thousand AUD | 115.96% |
| 2010 FY | -2.12 Million AUD | 23.01% |
| 2009 FY | -2.75 Million AUD | -7.7% |
| 2008 FY | -2.56 Million AUD | 4.02% |
| 2007 FY | -2.66 Million AUD | 15.38% |
| 2006 FY | -3.15 Million AUD | -25.44% |
| 2005 FY | -2.51 Million AUD | -27.84% |
| 2004 FY | -1.96 Million AUD | 19.05% |
| 2003 FY | -2.42 Million AUD | -121.18% |
| 2002 FY | -1.09 Million AUD | 71.56% |
| 2001 FY | -3.86 Million AUD | 12.28% |
| 2000 FY | -4.4 Million AUD | 10.24% |
| 1999 FY | -4.9 Million AUD | -8.52% |
| 1998 FY | -4.51 Million AUD | -68.21% |
| 1997 FY | -2.68 Million AUD | 43.19% |
| 1996 FY | -4.72 Million AUD | -135.93% |
| 1995 FY | -2 Million AUD | -67.14% |
| 1994 FY | -1.19 Million AUD | -156.2% |
| 1993 FY | -468 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -96.321% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 2967.469% |
| SQZ Biotechnologies Company | -75.82 Million USD | -85.863% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -689.66% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 272.178% |
| Mesoblast Limited | -84.14 Million USD | -67.482% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -9074.883% |
| Genus plc | 6.4 Million USD | 2302.042% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 1546.562% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -15031.386% |
| Marizyme, Inc. | -34.08 Million USD | -313.45% |
| ContraFect Corporation | -56.88 Million USD | -147.729% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -1587.793% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -2994.164% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -9952.183% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -4844.057% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -5023.19% |
| MultiCell Technologies, Inc. | -722.81 USD | -19497513.481% |
| Accustem Sciences Inc. | -3.74 Million USD | -3661.744% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -138.906% |
| EV Biologics, Inc. | -483.06 Thousand USD | -29074.454% |
| Q BioMed Inc. | -3.44 Million USD | -3990.145% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 4081.093% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -36075.963% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -5263.635% |
| Biomind Labs Inc. | -1 Million USD | -13859.022% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -2788.194% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -2019.891% |
| Skye Bioscience, Inc. | -13.67 Million USD | -930.813% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -6994.497% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -470421.835% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -2693.759% |
| IMV Inc. | -38.67 Million USD | -264.43% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -788.047% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -7192.247% |
| GB Sciences, Inc. | -1.42 Million USD | -9821.141% |
| Alpha Cognition Inc. | -9.7 Million USD | -1352.055% |
| HST Global, Inc. | -140.9 Thousand USD | -99916.82% |
| CSL Limited | 3.7 Billion USD | 103.807% |
| Halberd Corporation | -75.05 Thousand USD | -187682.412% |
| Enzolytics Inc. | -2.14 Million USD | -6458.577% |
| Resverlogix Corp. | -12.74 Million USD | -1005.426% |
| Affymax, Inc. | -15.04 Million USD | -836.666% |
| SYBLEU INC | -149.18 Thousand USD | -94370.237% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -4348.185% |
| argenx SE | -425.04 Million USD | 66.844% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -153.893% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -13399.109% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -8823.307% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -4038.959% |
| AVAX Technologies, Inc. | 6.69 Million USD | 2205.681% |
| Zenith Capital Corp. | -8.94 Million USD | -1475.877% |
| Genscript Biotech Corporation | -415.79 Million USD | 66.105% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -808870.208% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -5639.817% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -82070.764% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -156.366% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -4757.586% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -14221.454% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -7459.159% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -11120.597% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -6929.815% |
| BioStem Technologies, Inc. | -7.77 Million USD | -1711.689% |
| ONE Bio Corp. | 13.68 Million USD | 1130.079% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -77554.186% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -10453.2% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -12428.22% |
| Agentix Corp. | -1.37 Million USD | -10173.744% |
| LadRx Corporation | -3.82 Million USD | -3585.787% |
| Cell Source, Inc. | -4.32 Million USD | -3158.253% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -33820.054% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -20415.423% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -20415.423% |
| NovAccess Global Inc. | -2.46 Million USD | -5613.191% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -4727.313% |
| Itoco Inc. | -919.14 Thousand USD | -15232.887% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -3225.081% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -12494.343% |
| Kadimastem Ltd | -3.04 Million USD | -4535.497% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -53746.656% |
| CytoDyn Inc. | -18.05 Million USD | -680.434% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -559815.375% |
| Mobile Lads Corp. | -554.55 Thousand USD | -25313.524% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -63936.705% |
| Qrons Inc. | -643.67 Thousand USD | -21794.63% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -24855.722% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -6220.105% |
| Rebus Holdings, Inc. | -664 Thousand USD | -21124.503% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -7659.134% |
| International Stem Cell Corporation | -663 Thousand USD | -21156.516% |
| Bioxytran, Inc. | -3.82 Million USD | -3589.143% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -267625.494% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -692774.631% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -288.603% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -8610.179% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -19052.487% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -4430.077% |
| Neutra Corp. | -229.48 Thousand USD | -61311.459% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -703.528% |
| PureTech Health plc | -146.19 Million USD | 3.604% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -555.762% |
| IXICO plc | -1.43 Million USD | -9707.286% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -1384.888% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -15.701% |
| CSL Limited | 3.81 Billion USD | 103.697% |
| Cellectis S.A. | -108.85 Million USD | -29.464% |